MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
BBLG — Bone Biologics Corp Common Stock
NasdaqBone Biologics Corp Common Stock
$0.48
+0.00(+0.08%)
- O
- 0.48
- H
- 0.48
- L
- 0.47
- V
- 15.52K
⏱️ End-of-day dataAs of Oct 2, 2026
BBLG — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| Cash And Cash Equivalents | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| Prepaid Assets | 441,456.00 | 451,918.00 | 301,715.00 | 361,748.00 | 415,505.00 | 536,238.00 |
| Total Current Assets | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| Accounts Payable | 308,948.00 | 417,884.00 | 333,081.00 | 403,729.00 | 247,843.00 | 373,042.00 |
| Other Current Liabilities | 438.00 | 703.00 | 1,201.00 | 2,413.00 | 3,315.00 | 4,670.00 |
| Total Current Liabilities | 309,386.00 | 418,587.00 | 334,282.00 | 406,142.00 | 251,158.00 | 377,712.00 |
| Total Non Current Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 309,386.00 | 418,587.00 | 334,282.00 | 406,142.00 | 251,158.00 | 377,712.00 |
| Common Stock | 1,795.00 | 1,795.00 | 1,795.00 | 1,685.00 | 3,270.00 | 2,953.00 |
| Retained Earnings | $-88.90M | $-88.13M | $-87.45M | $-86.78M | $-86.04M | $-85.02M |
| Total Shareholders Equity | $4.67M | $5.38M | $6.02M | $6.60M | $2.91M | $3.48M |
| Additional Paid In Capital | $93.56M | $93.51M | $93.46M | $93.37M | $88.95M | $88.50M |
| Accrued Expenses | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Deferred Revenue | N/A | N/A | N/A | N/A | N/A | 0.00 |